ANKITA PATEL: Open Payments
NPI 1184859928 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,850 in 153 payments from 19 companies in 2025. Trend: 2023 $2,935 · 2024 $2,948 · 2025 $2,850
Food & beverage: $2,755Education: $95
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 36 | $407 |
| Lilly USA, LLC | 16 | $268 |
| Janssen Biotech, Inc. | 11 | $249 |
| ABBVIE INC. | 12 | $240 |
| Organon LLC | 13 | $216 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $208 |
| UCB, Inc. | 9 | $205 |
| PFIZER INC. | 14 | $201 |
| Incyte Corporation | 10 | $194 |
| GENZYME CORPORATION | 3 | $124 |
Products named: NEMLUVIO, TREMFYA, TALTZ, Bimzelx, CIBINQO, OPZELURA, DUPIXENT, VTAMA.
Industry payments across IL — which companies pay providers there.
